✦ LIBER ✦

Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma

✍ Scribed by M. Hänel; N. Kröger; S. Sonnenberg; M. Bornhäuser; W. Krüger; F. Kroschinsky; A. Hänel; B. Metzner; J. Birkmann; B. Schmid; M. Hoffknecht; F. Fiedler; G. Ehninger; A. Zander

Book ID: 105988002
Publisher: Springer
Year: 2002
Tongue: English
Weight: 73 KB
Volume: 81
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-001-0413-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Busulfan, cyclophosphamide and etoposide

Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy

✍ Kröger, N; Hoffknecht, M; Hänel, M; Krüger, W; Zeller, W; Stockschläder, M; de W 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 46 KB

Busulfan and cyclophosphamide (BU/CY2) a

Busulfan and cyclophosphamide (BU/CY2) as preparative regimen for patients with lymphoma

✍ deMagalhaes-Silverman, M; Lister, J; Rybka, W; Wilson, J; Ball, E 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

High-dose melphalan versus busulfan, cyc

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma

✍ Don M. Benson Jr.; Patrick J. Elder; Thomas S. Lin; William Blum; Sam Penza; Bel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Autotransplantation following busulfan,

Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin’s lymphoma

✍ Copelan, E A; Penza, S L; Pohlman, B; Avalos, B R; Goormastic, M; Andresen, S W; 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 74 KB

High dose busulfan/etoposide as a prepar

High dose busulfan/etoposide as a preparatory regimen for second bone marrow transplants in hematologic malignancies

✍ Blume, K. G. ;Forman, S. J. 📂 Article 📅 1987 🏛 Springer-Verlag ⚖ 281 KB

Five patients with hematologic malignancies who had relapsed between seven months and eight years after their primary bone marrow transplants were prepared with high dose busulfan/etoposide for second marrow transplantations from the same donors who had provided the marrow for the primary transplant

High-dose cyclophosphamide, etoposide an

High-dose cyclophosphamide, etoposide and BCNU (CVB) with autologous stem cell rescue in malignant lymphomas

✍ C. Patti; I. Majolino; R. Scimè; A. Indovina; S. Vasta; G. Liberti; S. Gentile; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 667 KB